[1] Shi S, Tang Y, Zhao Q, et al.Prevalence and risk of atrial fibrillation in China: A national cross-sectional epidemiological study[J].Lancet Reg Health West Pac,2022,23:100439.
[2] 丁宇,王海军,尹新华,等.高龄心房颤动患者抗凝治疗中国专家共识(2024)[J].中华老年心脑血管病杂志,2024,26(10):1113-1124.
[3] Du X,Guo L,Xia S,et al.Atrial fibrillation prevalence,awareness and management in a nationwide survey of adults in China[J]. Heart,2021,107(7):535-541.
[4] R K,Aziz M ,John C.Persistent Atrial Fibrillation: The Role of Left Atrial Posterior Wall Isolation and Ablation Strategies[J].Journal of Clinical Medicine,2021,10(14):3129-3129.
[5] 杨再鑫,杨一桢,石亮,等.左心房基质重构在阵发性心房颤动射频消融术后超远期复发中的作用[J].临床心血管病杂志,2024,40(6):488-493.
[6] 台楠. 二尖瓣轻中度关闭不全对心房颤动导管消融复发的预测分析[D].吉林大学,2023.
[7] Atar D, Berge E, Le Heuzey JY, et al.The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events[J].Europace,2020,22(2) :195-204.
[8] Soo M C,Seob H P,Jin M C, et al.Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation[J].Scientific Reports,2021,11(1):23808-23808.
[9] Shaobo S,Qingyan Z,Tao L, et al.Left Atrial Thrombus in Patients With Non-valvular Atrial Fibrillation: A Cross-Sectional Study in China[J].Frontiers in Cardiovascular Medicine,2022,9827101-827101.
[10] Al-Gibbawi M, Ayinde H O, Bhatia N K, et al.Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke[J]. Heart Rhythm, 2021, 18(3): 338-346.
[11] 王越,郑汝杰,江耀辉,等.左心房容积指数与心房颤动患者导管消融术后房颤复发的相关性研究[J].中国循证心血管医学杂志,2022,14(8):932-935.
[12] 酉鹏华,陈海潮,韩稳琦.心房颤动患者射频消融术后1年内复发的影响因素及其预测模型构建[J].实用心脑肺血管病杂志,2024,32(6):22-25.
[13] 卓伟东,傅国华,王彬浩,等. 房颤患者一站式手术与导管射频消融术后长期口服抗凝药物的5年随访结果比较[J]. 中华心血管病杂志,2023,51(9):951-957.
[14] John J, Garg L,0rosey M,et a1.The effect of esophageal cooling on esophageal injury during radiofrequency catheter ablation of atrial fibrillation[J].J Interv Card Elecophysiol,2020,58(1): 43-50.
[15] Sun Y, Chen X, Zhang Y, et al.Reverse Atrial Remodeling in Heart Failure With Recovered Ejection Fraction[J]. J Am Heart Assoc, 2023,12(2):e026891.
[16] 廉玉蓉,王芳,段续敏,等. 持续性心房颤动患者首次射频消融术后1年复发的影响因素[J]. 实用心脑肺血管病杂志,2023,31(8):8-11,16.
[17] Tanaka N, Inoue K, Kobori A, et al.Atrial Fibrillation Ablation Outcomes and Heart Failure (from the Kansai Plus Atrial Fibrillation Registry)[J]. Am J Cardiol, 2023, 189: 108-118.
[18] Yoshihiko K,Eitaro F,Satoshi F, et al.Association between left atrial reverse remodeling and maintenance of sinus rhythm after catheter ablation of persistent atrial fibrillation.[J].Heart and vessels,2020,35(2):239-245.
[19] 郭静,张勇,张宁,等.心房颤动患者射频消融术后复发的因素与对策[J].中国心脏起搏与心电生理杂志,2023,37(6):520-523.
[20] 韩蕊,梅迎晨,郑梅,等.阵发性心房颤动患者经导管射频消融术后左心房变化及复发的危险因素分析[J].解放军医药杂志,2021,33(9):62-68.
[21] 吴云. 阵发性房颤射频消融术后心功能的变化[J].中国疗养医学,2021,30(2):189-190.
[22] Wang X, Song B, Qiu C, et al.The effect of left atrial remodeling after cryoballoon ablation and radiofrequency ablation for paroxysmal atrial fibrillation[J]. Clin Cardiol, 2021, 44(1): 78-84.
[23] 李伊,王威,周国锋.左心房相关影像预测房颤射频消融术后复发的进展[J].临床放射学杂志,2024,43(11):1995-1999.
[24] Assaf A,Mekhael M,Noujaim C,et al. Effect of fibrosis regionality on atrial fibrillation recurrence:insights from DECAAFⅡ[J]. Europace,2023,25(9):euad199.
[25] 洪昕,张南南,徐桂冬.左房纤维化在心房颤动导管消融术后复发中的研究进展[J].南京医科大学学报(自然科学版),2024,44(8):1165-1173.
[26] L. P,L. E,B. C, et al.Long-term effect of atrial fibrillation on the evolution of mitral and tricuspid valve regurgitation[J].Acta Cardiologica,2020,75(7):639-647.
[27] 王芳,段续敏,卫政,等.功能性二尖瓣反流与心房颤动射频消融术后早期心力衰竭的相关性[J].临床内科杂志,2024,41(10):678-682.
[28] 宁小平,陆方林,徐志云,等.心房功能性二尖瓣反流研究进展[J].国际心血管病杂志,2021,48(5):277-280.
[29] 黄火旺,李鹏,韩燊,等.心房功能性二尖瓣反流的研究进展[J].中国胸心血管外科临床杂志,2024,31(9):1369-1375.
[30] 马南,鲍春荣,魏柯,等. 重度房性功能性二尖瓣反流合并心房颤动的外科治疗策略[J]. 中华胸心血管外科杂志,2024,40(10):607-611.
[31] 张航,石凤梧.房性功能性二尖瓣关闭不全的经导管微创化治疗[J].中国介入心脏病学杂志,2022,30(9):697-700.
[32] 李安妮,高小瞻,周畅.二维斑点追踪技术及实时三维超声心动图评估心房功能性二尖瓣反流患者导管消融疗效及其影响因素分析[J].临床超声医学杂志,2024,26(4):334-339.
[33] 强超华,王跃涛,杨珍妮,等.阵发性心房颤动患者术前功能性二尖瓣反流程度与射频消融术后复发的相关性[J].临床超声医学杂志,2021,23(11):806-810.
[34] Zhao DQ, Zhang FT, Liu XJ, et al.Efficacy of catheter ablation for atrial fibrillation in patients with significant functional mitral regurgitation[J]. Medicine (Baltimore), 2023, 102(10):e33231.
[35] Abe Y,Takahashi Y,Shibata T.A new disease entity:a trial functional mitral regurgitation[J].J Cardiol,2021,77(6):565-569.
[36] Zhao D, Zhang F, Liu X, et al.Efficacy of catheter ablation for atrial fibrillation in patients with significant functional mitral regurgitation[J]. Medicine, 2023, 102(10): e33231.
[37] Tao J W,Qing D Z,Tao F Z, et al.Effect of catheter ablation on clinical outcomes in patients with atrial fibrillation and significant functional mitral regurgitation[J].BMC Cardiovascular Disorders,2021,21(1):587-587.
[38] 李顺祥,黄卓山,李苏华,等. 射频消融术对改善心房颤动合并功能性二尖瓣反流患者心脏结构与功能的作用[J]. 中华心血管病杂志,2024,52(10):1170-1176.
[39] Laurie S,Sylvie L,Karima A, et al.Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation.[J].Journal of the American College of Cardiology,2022,79(10):951-961.
[40] 赵丹清,张付涛,刘晓洁,等.心房颤动合并功能性二尖瓣反流的危险因素分析及导管消融的影响[J].临床心血管病杂志,2022,38(5):368-372.
[41] Nishiwaki S, Watanabe S, Yoneda FMA, et al.Impact of catheter ablation on functional tricuspid regurgitation in patients with atrial fibrillation[J]. J Interv Card Electrophysiol, 2023, 66(6):1441-1453. |
